Hostname: page-component-7c8c6479df-fqc5m Total loading time: 0 Render date: 2024-03-28T22:06:57.469Z Has data issue: false hasContentIssue false

Insight and Recovery in Schizophrenia: an Observational Study

Published online by Cambridge University Press:  15 April 2020

D. Cannavo'
Affiliation:
Psychiatry, University of Catania, Catania, Italy
F. Battaglia
Affiliation:
Psychiatry, University of Catania, Catania, Italy
E. Battaglia
Affiliation:
Psychiatry, University of Catania, Catania, Italy
G. Minutolo
Affiliation:
Psychiatry, University of Catania, Catania, Italy
E. Aguglia
Affiliation:
Psychiatry, University of Catania, Catania, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Definitions of therapeutic outcome in schizophrenia include both maintained symptomatic remission and appropriate functioning. In schizophrenic patients insight is associated with positive (better compliance and recovery) and negative outcomes (depression, low self-esteem and quality of life).

Objectives

To evaluate the correlation between insight and recovery in schizophrenic patients according to criteria for both symptomatic and functional remission.

Aims

To demonstrate how high levels of insight are positively correlated with recovery.

Methods

70 schizophrenic patients who switched or started a new pharmacological treatment were tested using Schedule for the Assessment of Insight, Positive and Negative Syndrome Scale, Short Form questionnaire, Psychological General Well-Being Index and Global Assessment of Functioning scale at baseline, 12 and 24 months.

Results

After 2 years, 50% of the subjects achieved symptom remission and 25.5% had adequate social functioning for 2 years or more. Only 12% of subjects met full recovery criteria for 2 years or longer. Patients in remission showed a better outcome on all PANSS subscales, an improvement in social functioning and in subjective well-being. No differences in terms of Quality of life between groups. All patients in recovery showed an improvement of insight, especially those treated with SGA. Recovery after 2 years was predicted by female sex, higher age, pre-morbid social adaptation and low level of negative symptoms at baseline.

Conclusions

The results indicate that only 12% of patients achieve recovery and suggest that social functioning, compliance, type of antipsychotic and improvement in insight levels represent important predictors for recovery.

Type
Article: 1748
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.